Showing results (11-20 of 35) with videos related to
Sort By:
Pageof 4
Current Medicinal Chemistry|September 22, 2017
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel DiseaseMarianna Lucafò, Biljana Stankovic, Nikola Kotur, et al.Life (Basel, Switzerland)|October 27, 2022
Genetic Aspects of Micronutrients Important for Inflammatory Bowel DiseaseSanja Dragasevic, Biljana Stankovic, Nikola Kotur, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 2, 2019
Influence of variants in folate metabolism genes on 6-mercaptopurine induced toxicity during treatment for childhood acute lymphocytic leukemiaGoran Milosevic, Nikola Kotur, Jelena Lazic, et al.Pharmacogenomics|September 29, 2015
TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent mannerNikola Kotur, Lidija Dokmanovic, Dragana Janic, et al.Hemoglobin|September 22, 2010
Thalassemia syndromes in Serbia: an updateMilena Radmilovic, Branka Zukic, Biljana Stankovic, et al.Annals of Hematology|November 20, 2012
Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobinMilena Radmilovic, Branka Zukic, Maja Stojiljkovic Petrovic, et al.Radiology and Oncology|September 14, 2018
Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemiaVladimir Gasic, Branka Zukic, Biljana Stankovic, et al.Frontiers in Pharmacology|October 24, 2024
The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activityDebora Curci, Biljana Stankovic, Nikola Kotur, et al.Journal of Applied Genetics|July 23, 2016
New PAH gene promoter KLF1 and 3'-region C/EBPalpha motifs influence transcription in vitroKristel Klaassen, Biljana Stankovic, Nikola Kotur, et al.Genes|April 30, 2020
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia TreatmentNikola Kotur, Jelena Lazic, Bojan Ristivojevic, et al.Pageof 4